Translational Research
Accelerating the clinical application of promising research findings
Home » Translational Research » Research Faculty » Here
In this section
Levy, Samuel, Ph.D.
Scripps Translational Science Institute
and Scripps Genomic Medicine
Professor of Molecular and Experimental Medicine
The Scripps Research Institute
Samuel Levy, Ph.D., Director of Genomic Sciences, has an ongoing interest in characterizing and refining the structure and function of the genome and epigenome in human populations. He also is Professor of Molecular and Experimental Medicine at The Scripps Research Institute.
During his tenure as Director and Professor in Human Genomics at the J. Craig Venter Institute, Dr. Levy was the leading scientist on the first published diploid genome sequence of a human, J. Craig Venter, Ph.D., and he led ongoing studies of functional characterization of DNA variants in protein coding and cis-regulatory regions prior to joining STSI in 2009. Dr. Levy also provided contract-based gene re-sequencing services for the National Heart, Lung and Blood Institute (NHLBI) and has worked with over 10 different research groups over the last three years providing high throughput discovery of DNA variants on clinical samples for disease association studies. Among his current STSI projects is the Human Tumor Sequencing study.
Prior to joining JCVI in 2002, Dr. Levy worked at Celera Genomics for a three-year period and was involved in developing computational tools for gene discovery and functional annotation in the Drosophila and human genome sequences. Prior to his work at Celera Genomics, from 1989-1999, Dr. Levy was a postdoctoral worker and then independent investigator in the Molecular, Cellular and Developmental Biology (MCDB) Department at the University of Colorado at Boulder. At MCDB, he worked on a variety of projects ranging from extracellular Golgi-based trafficking in plants, plant cell wall development and structure-function relationship in complex carbohydrates using a range of approaches involving biochemistry, cell biology and computational chemistry.
In 1982, Dr. Levy received a B.Sc. in Molecular Biophysics at the University of Leeds, UK, and in 1986 was awarded the Ph.D., in cell and computational biology at the University of Bristol, UK. He was in receipt of a NATO/SERC postdoctoral fellowship for a two-year period studying structural and biochemical changes in plant cell walls at the École Normale Supérieure, France.
